China

Home / China / Latest

Sinopharm applies for vaccine market approval

chinadaily.com.cn | Updated: 2020-11-25 14:29

Share

Share - WeChat

A staff member displays a sample of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group Co Ltd (Sinopharm) in Beijing, capital of China, April 10, 2020. [Photo/Xinhua]

Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to the top market regulator, according to media reports.

Photo

Dagetu Lake adds pink splash to Badain Jaran Desert

China's northernmost high-speed rail starts service

Light displays dazzle international art fest in Beijing

Spectacular moon illuminates Mid-Autumn skylines

Giant flower basket draws crowds at Tian'anmen Square

URKL robot combat city tour debuts in Shanghai's Baoshan district

Latest

State Council News

China's economy in August 2026

Exclusive

How China's 'backyard program' works for Africa

Hands off! Do robots do it all by themselves?

Middle school students teach humanoid robots to dance!

Newsmaker

Steady hand at the bus wheel draws visitors

Wartime tales connect with intl friendship

Special Coverage

Loyalty and Honor without Borders

105th founding anniv. of the CPC

BACK TO THE TOP

English

中文

Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.

Registration Number: 130349

About China Daily

Advertise on Site

Expat Employment

FOLLOW US